Skip to main content

Endoscopic Screening and Surveillance: Indications and Standards

  • Chapter
  • First Online:
Early Neoplasias of the Gastrointestinal Tract

Abstract

Endoscopy is the gold standard for detection of early cancer in the gastrointestinal tract. For normal-risk asymptomatic persons, endoscopic screening of the upper and lower gastrointestinal tract is recommended in Japan starting at the age of 40 years. In many Western countries, colonoscopy only is approved for cancer screening starting at the age of 50 years. As rationale serves that colonoscopic screening with resection of all neoplastic lesions had strongly reduced the incidence of colorectal cancer during subsequent follow-up for 10 years. High-risk groups are subject to different, more frequent endoscopic surveillance programs which we summarize for esophageal, gastric, and colorectal cancer. We explain the preparation and procedural steps of screening colonoscopy and esophago-/gastroscopy including benchmark criteria for quality of endoscopic screening.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. GLOBOCAN database, International Agency for Research on Cancer, WHO. http://globocan.iarc.fr/.

  2. Boyle P, et al. World cancer report 2008. WHO Press; 2008.

    Google Scholar 

  3. Everett SM, et al. Early gastric cancer in Europe. Gut. 1997;41:142–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Morita S, et al. Outcome of pylorus-preserving gastrectomy for early gastric cancer. Br J Surg. 2008;95:1131–5.

    Article  CAS  PubMed  Google Scholar 

  5. Abe S, et al. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy. 2013;45:703–7.

    Article  PubMed  Google Scholar 

  6. Gotoda T, et al. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–71.

    Article  CAS  PubMed  Google Scholar 

  7. Saito H. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum. 2000;43:S78–84.

    Article  CAS  PubMed  Google Scholar 

  8. Levin B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95.

    Article  CAS  PubMed  Google Scholar 

  9. Watanabe T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17:1–29.

    Article  PubMed  Google Scholar 

  10. Pox C, et al. S3-guideline colorectal cancer version 1.0. Z Gastroenterol. 2013;51:753–854.

    Article  CAS  PubMed  Google Scholar 

  11. Fletcher RH, et al. Screening patients with a family history of colorectal cancer. J Gen Intern Med. 2007;22:508–13.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Hirota WK, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570–80.

    Article  PubMed  Google Scholar 

  13. Vasen HF, et al. Familial colorectal cancer risk: ESMO clinical recommendations. Ann Oncol. 2009;20 Suppl 4:51–3.

    PubMed  Google Scholar 

  14. Zauber AG, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Center MM, et al. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18:1688–94.

    Article  PubMed  Google Scholar 

  16. Jemal A, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

    Article  PubMed  Google Scholar 

  17. Hamashima C, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008;38:259–67.

    Article  PubMed  Google Scholar 

  18. Leung WK, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–87.

    Article  PubMed  Google Scholar 

  19. Watabe H, et al. Predicting the development of gastric cancer from combining helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Lau M, et al. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006;101:2485–92.

    Article  PubMed  Google Scholar 

  21. Towler B, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ. 1998;317:559–65.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Sieg A, et al. Results of coloscopy screening in 200--n Internet-based documentation. Dtsch Med Wochenschr. 2006;131:379–83.

    Google Scholar 

  23. Winawer SJ, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594–642.

    Article  CAS  PubMed  Google Scholar 

  24. Winawer S, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544–60.

    Article  PubMed  Google Scholar 

  25. Johns LE, et al. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003.

    Article  CAS  PubMed  Google Scholar 

  26. Dunlop MG. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut. 2002;51 Suppl 5:V21–7.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Giardiello FM, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447–53.

    Article  CAS  PubMed  Google Scholar 

  28. Farraye FA, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746–74. 774 e741-744; quiz e712-743.

    Article  PubMed  Google Scholar 

  29. Rutter MD, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–8.

    Article  PubMed  Google Scholar 

  30. Dove-Edwin I, et al. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ. 2005;331:1047.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Itzkowitz SH, et al. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–21.

    Article  PubMed  Google Scholar 

  32. Lee KJ, et al. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer. 2006;118:2315–21.

    Article  CAS  PubMed  Google Scholar 

  33. Huntsman DG, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001;344:1904–9.

    Article  CAS  PubMed  Google Scholar 

  34. Engel LS, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–13.

    Article  PubMed  Google Scholar 

  35. Kuwano H, et al. Guidelines for diagnosis and treatment of neoplasias of the esophagus. April 2007 edition: part I. Edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.

    Article  Google Scholar 

  36. Ribeiro Jr U, et al. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996;83:1174–85.

    Article  PubMed  Google Scholar 

  37. Erkal HS, et al. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol. 2001;19:1358–62.

    CAS  PubMed  Google Scholar 

  38. Ina H, et al. The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer. Screening results using Lugol dye endoscopy. Cancer. 1994;73:2038–41.

    Article  CAS  PubMed  Google Scholar 

  39. Appelqvist P, et al. Lye corrosion carcinoma of the esophagus: a review of 63 cases. Cancer. 1980;45:2655–8.

    Article  CAS  PubMed  Google Scholar 

  40. Sandler RS, et al. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA. 1995;274:1359–62.

    Article  CAS  PubMed  Google Scholar 

  41. Stevens HP, et al. Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol. 1996;132:640–51.

    Article  CAS  PubMed  Google Scholar 

  42. Abnet CC, et al. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst. 2005;97:301–6.

    Article  CAS  PubMed  Google Scholar 

  43. Mark SD, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst. 2000;92:1753–63.

    Article  CAS  PubMed  Google Scholar 

  44. Shuyama K, et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer. 2007;96:1554–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Spechler SJ, et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91.

    Article  PubMed  Google Scholar 

  46. Oettle GJ, et al. Esophagitis in a population at risk for esophageal carcinoma. Cancer. 1986;57:2222–9.

    Article  CAS  PubMed  Google Scholar 

  47. El-Serag HB, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50:368–72.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Buttar NS, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630–9.

    Article  CAS  PubMed  Google Scholar 

  49. Lagergren J, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.

    Article  CAS  PubMed  Google Scholar 

  50. Gray MR, et al. The role of smoking and alcohol in metaplasia and cancer risk in Barrett’s columnar lined oesophagus. Gut. 1993;34:727–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Faigel DO, et al. Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol. 2006;101:866–72.

    Article  PubMed  Google Scholar 

  52. Kudo S, et al. The problem of de novo colorectal carcinoma. Eur J Cancer. 1995;31A:1118–20.

    Article  CAS  PubMed  Google Scholar 

  53. Okawa K, et al. Colonoscopy. In: Arakawa T editor. Learning skills for gastrointestinal endoscopy. Basic knowledge and strategies: lessons from Japan. Tokyo: The Asahi Shimbun Company; 2006. p. 96–117.

    Google Scholar 

  54. Oyama T. Endoscopic diagnosis of gastric adenocarcinoma for ESD. Tokyo: Nankodo Co., Ltd.; 2010.

    Google Scholar 

  55. Oyama T. Diagnostic strategies of superficial Barrett’s esophageal cancer for endoscopic submucosal dissection. Dig Endosc. 2013;25 Suppl 1:7–12.

    Article  PubMed  Google Scholar 

  56. Uchido T, et al. Esophagogastroduodenoscopy. In: Arakawa T editor. Learning skills for gastrointestinal endoscopy. Basic knowledge and strategies: lessons from Japan. Tokyo: The Asahi Shimbun Company; 2006. p. 18–40.

    Google Scholar 

  57. Anderson MA, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009;70:1060–70.

    Article  PubMed  Google Scholar 

  58. Banerjee S, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67:791–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge Toshio Uroaka MD for critical discussion and improvements in the manuscript of this chapter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frieder Berr .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Berr, F., Ponchon, T., Oyama, T. (2014). Endoscopic Screening and Surveillance: Indications and Standards. In: Berr, F., Oyama, T., Ponchon, T., Yahagi, N. (eds) Early Neoplasias of the Gastrointestinal Tract. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8292-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8292-5_1

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-8291-8

  • Online ISBN: 978-1-4614-8292-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics